Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
KLR
Kailera Therapeutics
KLRA
Debt-to-equity
Debt-to-equity at other companies
Semtech
SMTC
0.9×
-0.1×
Synopsys
SNPS
0.4×
-0.7×
Nucor
NUE
0×
0.0×
Northern Trust
NTRS
0×
0.0×
Dycom Industries
DY
1.6×
+0.7×
Berkshire Hathaway
BRK.A
0×
0.0×
Other financials
Income statement
See full
Operating income
-$84.7M
-314%
Net income
-$78.9M
-339%
EPS (diluted)
-$3,650.00
+79.7%
Balance sheet
See full
Cash & equivalents
$111.8M
+9.9%
Total debt
$10.5M
—
Total equity
-$432.1M
-83.7%
Total assets
$624.8M
—
Cash flow
See full
Operating cash flow
-$68.3M
-275%
Valuation
See full
Market cap
$2.44B
-15.8%
Enterprise value
$2.34B
—
Returns & leverage
See full
Current ratio
9.7×
—
Watchlist
Screener
Filings
Earnings
Charts